• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

罗克斯指数对预测呼吸衰竭患者插管及重症监护病房预后的价值。

Value of Rox Index to Predict Intubation and Intensive Care Unit Outcome in Patients with Respiratory Failure.

作者信息

Mammadova Ayshan, Eriş Esra, Solmaz Zeynep Sena, Kara Ayşe Taşçı, Atasoy Aydın, Gürsel Gül

机构信息

Gazi University School of Medicine, Department of Pulmonary Disease, Division of Critical Care Medicine Gazi University.

Gazi University School of Medicine Critical Care Fellowship Program Gazi University Turkey.

出版信息

Rev Recent Clin Trials. 2022 Jun 6. doi: 10.2174/1574887117666220606114549.

DOI:10.2174/1574887117666220606114549
PMID:35670348
Abstract

BACKGROUND

Recent literature suggests that the respiratory rate oxygenation (ROX) index may be a useful parameter in predicting intubation indication in hypoxemic patients.

OBJECTIVE

In this study, we evaluated the accuracy of the ROX index in predicting intubation, length of stay in the ICU, and mortality in ICU patients with hypoxemic respiratory failure with and without hypercapnia.

METHODS

Single-centre retrospective cohort study of 290 patients, with a preliminary diagnosis of respiratory failure, who were treated with low flow oxygen systems. Demographics, medical history, clinical, laboratory, treatment, and prognostic data were obtained from the electronic records of the hospital. The ROX index was calculated at the time of ICU admission.

RESULTS

Thirty-seven percent of non-hypercapnic and 69% of hypercapnic patients were intubated (p:0.005). In hypercapnic patients, ROX: 6.9 had highest sensitivity (81%) and specificity (65%) values for intubation (p:0.005). In non-hypercapnic patients, ROX: 6.2 had the highest sensitivity (81%) and specificity (40%) values. While 11% of hypercapnic patients and 30% of non-hypercapnic patients were died (p:0.05), 22% of hypercapnic patients and 33% of non-hypercapnic patients stayed in the ICU longer than 14 days (p:0.044). The highest sensitivity and specificity values were found for mortality in hypercapnic patients; for ROX value of 5.94 (sensitivity:86%, specificity:61%) and for ICU stay longer than 14 days; for ROX value of 7.4 (sensitivity:71%, specificity:68%).

CONCLUSION

Results of our study suggest that ROX index calculated during ICU admission can be helpful in predicting intubation indication and length of ICU stay in patients with respiratory failure and hypercapnia may influence the cutoff values.

摘要

背景

近期文献表明,呼吸频率氧合(ROX)指数可能是预测低氧血症患者插管指征的有用参数。

目的

在本研究中,我们评估了ROX指数在预测合并或不合并高碳酸血症的低氧性呼吸衰竭ICU患者的插管情况、ICU住院时间和死亡率方面的准确性。

方法

对290例初步诊断为呼吸衰竭并接受低流量氧疗系统治疗的患者进行单中心回顾性队列研究。从医院电子记录中获取人口统计学、病史、临床、实验室、治疗和预后数据。在ICU入院时计算ROX指数。

结果

37%的非高碳酸血症患者和69%的高碳酸血症患者接受了插管(p:0.005)。在高碳酸血症患者中,ROX:6.9时插管的敏感性(81%)和特异性(65%)最高(p:0.005)。在非高碳酸血症患者中,ROX:6.2时敏感性(81%)和特异性(40%)最高。11%的高碳酸血症患者和30%的非高碳酸血症患者死亡(p:0.05),22%的高碳酸血症患者和33%的非高碳酸血症患者在ICU停留时间超过14天(p:0.044)。高碳酸血症患者死亡率的敏感性和特异性值最高;ROX值为5.94时(敏感性:86%,特异性:61%),ICU停留时间超过14天时;ROX值为7.4时(敏感性:71%,特异性:68%)。

结论

我们的研究结果表明,ICU入院时计算的ROX指数有助于预测呼吸衰竭患者的插管指征,高碳酸血症可能会影响截断值。

相似文献

1
Value of Rox Index to Predict Intubation and Intensive Care Unit Outcome in Patients with Respiratory Failure.罗克斯指数对预测呼吸衰竭患者插管及重症监护病房预后的价值。
Rev Recent Clin Trials. 2022 Jun 6. doi: 10.2174/1574887117666220606114549.
2
Using the ROX Index to Predict Treatment Outcome for High-Flow Nasal Cannula and/or Noninvasive Ventilation in Patients With COPD Exacerbations.使用 ROX 指数预测 COPD 加重患者使用高流量鼻导管和/或无创通气的治疗结局。
Respir Care. 2024 Aug 24;69(9):1100-1107. doi: 10.4187/respcare.11544.
3
Respiratory rate-oxygenation index on the 3 day is the best predictor of treatment failure in COVID-19 patients.第3天的呼吸频率-氧合指数是新冠病毒肺炎患者治疗失败的最佳预测指标。
Monaldi Arch Chest Dis. 2024 Dec 31;94(4). doi: 10.4081/monaldi.2024.3033. Epub 2024 Oct 24.
4
Predictive performance of ROX index and its variations for NIV failure.ROX指数及其变体对无创通气失败的预测性能。
Med Intensiva (Engl Ed). 2025 Jul;49(7):502136. doi: 10.1016/j.medine.2025.502136. Epub 2025 Jan 13.
5
Non-invasive ventilation for the management of acute hypercapnic respiratory failure due to exacerbation of chronic obstructive pulmonary disease.无创通气用于治疗慢性阻塞性肺疾病急性加重所致的急性高碳酸血症性呼吸衰竭。
Cochrane Database Syst Rev. 2017 Jul 13;7(7):CD004104. doi: 10.1002/14651858.CD004104.pub4.
6
High-flow nasal cannulae for respiratory support in adult intensive care patients.用于成人重症监护患者呼吸支持的高流量鼻导管
Cochrane Database Syst Rev. 2017 May 30;5(5):CD010172. doi: 10.1002/14651858.CD010172.pub2.
7
Prognostic value of the oxygenation index measured during mechanical ventilation and weaning. A retrospective cohort study.机械通气及撤机过程中测得的氧合指数的预后价值。一项回顾性队列研究。
Monaldi Arch Chest Dis. 2025 Jul 21;95(2). doi: 10.4081/monaldi.2024.2840. Epub 2024 Jul 23.
8
Early versus late tracheostomy in people with multiple trauma.多发伤患者早期与晚期气管切开术的比较
Cochrane Database Syst Rev. 2025 Aug 6;8(8):CD015932. doi: 10.1002/14651858.CD015932.pub2.
9
Identifying risk factors and developing a nomogram for High Flow Nasal Cannula failure in patients with hypercapnic acute respiratory failure.识别高碳酸血症急性呼吸衰竭患者高流量鼻导管吸氧失败的危险因素并构建列线图。
Am J Emerg Med. 2025 Apr;90:157-163. doi: 10.1016/j.ajem.2025.01.046. Epub 2025 Jan 22.
10
Extracorporeal carbon dioxide removal for the treatment of acute hypoxaemic respiratory failure: the REST RCT.体外二氧化碳清除治疗急性低氧性呼吸衰竭:REST随机对照试验
Health Technol Assess. 2025 Jul;29(33):1-16. doi: 10.3310/GJDM0320.

引用本文的文献

1
Comparisons of mortality predictions of mROX, CURB-65, and APACHE II in patients with severe pneumonia: A retrospective cohort study.严重肺炎患者中mROX、CURB-65和APACHE II死亡率预测的比较:一项回顾性队列研究。
Medicine (Baltimore). 2025 Jun 13;104(24):e42931. doi: 10.1097/MD.0000000000042931.

本文引用的文献

1
The ROX index as a predictor of standard oxygen therapy outcomes in thoracic trauma.ROX 指数预测胸外伤患者标准氧疗结局的价值。
Scand J Trauma Resusc Emerg Med. 2021 Jun 21;29(1):81. doi: 10.1186/s13049-021-00876-4.
2
High-Flow Nasal Cannula for COVID-19 Patients: A Multicenter Retrospective Study in China.高流量鼻导管给氧用于新型冠状病毒肺炎患者:一项中国多中心回顾性研究
Front Mol Biosci. 2021 Apr 13;8:639100. doi: 10.3389/fmolb.2021.639100. eCollection 2021.
3
The ROX index can be a useful tool for the triage evaluation of COVID-19 patients with dyspnoea.
ROX 指数可作为一种有用的工具,用于对有呼吸困难的 COVID-19 患者进行分诊评估。
J Adv Nurs. 2021 Aug;77(8):3361-3369. doi: 10.1111/jan.14848. Epub 2021 Apr 1.
4
Role of ROX index in the first assessment of COVID-19 patients in the emergency department.ROX 指数在急诊科 COVID-19 患者初步评估中的作用。
Intern Emerg Med. 2021 Oct;16(7):1959-1965. doi: 10.1007/s11739-021-02675-2. Epub 2021 Mar 1.
5
Performance of the ROX index to predict intubation in immunocompromised patients receiving high-flow nasal cannula for acute respiratory failure.ROX指数对接受高流量鼻导管治疗急性呼吸衰竭的免疫功能低下患者插管预测的性能。
Ann Intensive Care. 2021 Jan 27;11(1):17. doi: 10.1186/s13613-021-00801-z.
6
Validity of ROX index in prediction of risk of intubation in patients with COVID-19 pneumonia.ROX 指数预测 COVID-19 肺炎患者插管风险的有效性。
Adv Respir Med. 2021;89(1):1-7. doi: 10.5603/ARM.a2020.0176. Epub 2021 Jan 20.
7
High-Flow Nasal Cannula Therapy in COVID-19: Using the ROX Index to Predict Success.高流量鼻导管治疗 COVID-19:使用 ROX 指数预测成功。
Respir Care. 2021 Jun;66(6):909-919. doi: 10.4187/respcare.08631. Epub 2020 Dec 16.
8
The index of oxygenation to respiratory rate as a prognostic factor for mortality in Sepsis.氧合指数与呼吸率比值作为脓毒症患者死亡率的预后因素。
Am J Emerg Med. 2021 Jul;45:426-432. doi: 10.1016/j.ajem.2020.09.052. Epub 2020 Sep 24.
9
High-flow nasal cannula for Acute Respiratory Distress Syndrome (ARDS) due to COVID-19.用于新型冠状病毒肺炎(COVID-19)所致急性呼吸窘迫综合征(ARDS)的高流量鼻导管吸氧法
Multidiscip Respir Med. 2020 Sep 16;15(1):693. doi: 10.4081/mrm.2020.693. eCollection 2020 Jan 28.
10
Predictors of successful separation from high-flow nasal oxygen therapy in patients with acute respiratory failure: a retrospective monocenter study.急性呼吸衰竭患者成功脱离高流量鼻导管给氧治疗的预测因素:一项回顾性单中心研究
Ann Intensive Care. 2019 Sep 11;9(1):101. doi: 10.1186/s13613-019-0578-8.